Tecon Biology Co.Ltd(002100) : Announcement on the progress of using some temporarily idle raised funds for cash management (December 15, 2021)

Tecon Biology Co.Ltd(002100)

Securities code: 002100 securities abbreviation: Tecon Biology Co.Ltd(002100)

Announcement No.: 2021-086

Bond Code: 128030 bond abbreviation: Tiankang convertible bond

Tecon Biology Co.Ltd(002100)

Announcement on the progress of cash management using some temporarily idle raised funds

The company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete without false

Records, misleading statements or major omissions.

Tecon Biology Co.Ltd(002100) (hereinafter referred to as "the company") was held on December 6, 2021

The 21st (Interim) meeting of the 7th board of directors and the 14th (Interim) meeting of the 7th board of supervisors were held,

The proposal on using part of the temporarily idle raised funds for cash management was deliberated and approved by the company

On the premise of ensuring that the normal progress of the investment plan of the raised funds and the safety of the raised funds are not affected, the use of non

The idle raised funds exceeding RMB 110 million shall be subject to cash management, and the validity period shall be considered by the board of directors of the company

Within 12 months from the date of adoption, within the above limit and validity period, the funds can be recycled and used. Company independence

Both the legislative director and the recommendation institution expressed their consent. For details, see the company's announcement on December 7, 2021

In the required information disclosure newspaper securities times and cninfo.com www.cn info. com.. cn. Days disclosed on

Announcement of Kang Jinyu Bio-Technology Co.Ltd(600201) Co., Ltd. on using some temporarily idle raised funds for cash management

<公告 编号:2021-077>

)。

The implementation progress of the company's use of some idle raised funds for cash management is hereby announced as follows:

1、 Details of cash management using some idle raised funds this time

The company purchased the following financial products with some idle raised funds, as follows:

Sequence: name of related products of the client's counterparty subscription amount expected annualized income value date maturity date capital incoming relationship (10000 yuan) rate (%) source

1 Tecon Biology Co.Ltd(002100) China Industrial And Commercial Bank Of China Limited(601398) unitless agreement 23430.671 15% - 1.65% deposit of temporary leisure Co., Ltd. in 2021 and 2022 December 14 to raise funds from Urumqi branch of the company on December 14

Tecon Biology Co.Ltd(002100)

2、 Approval procedures to be performed

The proposal on using part of the temporarily idle raised funds for cash management has been adopted at the 21st (Interim) meeting of the 7th board of directors and the 14th meeting of the 7th board of supervisors The (Interim) meeting was deliberated and approved, and the independent directors and the sponsor expressed their consent. The amount and time limit of this purchase of financial products are within the scope of approval, and there is no need to submit them to the board of directors and the general meeting of shareholders for deliberation.

3、 Cash management risk and risk control measures

1. Cash management risk

The company will intervene timely and appropriately according to the economic situation and changes in the financial market to ensure the safety of funds. However, the financial market is greatly affected by the macro-economy, so it is not excluded that the matter is affected by market fluctuations.

2. Risk control measures

In view of the above risks, the company will take the following measures to prevent risks and ensure the safety of funds:

(1) In order to control risks, the company will strictly abide by the principle of prudence, select cash management products with high safety and good liquidity, and clarify the amount, variety and term of cash management products, as well as the rights, obligations and legal liabilities of both parties, so as to make the risks within the tolerable and controllable range of the company's risks.

(2) The relevant personnel of the company's financial department will track the changes in the net value of the products in real time. If they find that there are risk factors that may affect the company's capital safety, adverse changes in profitability, losses of cash management products that are inconsistent with the situation at the time of purchase, they will take corresponding measures in time to control the risks.

(3) The company's internal audit department is responsible for auditing and supervising the use and custody of funds of cash management products;

(4) Independent directors and the board of supervisors have the right to supervise and inspect the use of funds, and can hire professional institutions to audit when necessary;

(5) The company will timely perform the obligation of information disclosure in accordance with the relevant provisions of the CSRC and Shenzhen Stock Exchange.

4、 Impact of this cash management event on the company

The company uses part of the temporarily idle raised funds for cash management on the premise of ensuring that the normal progress of the investment plan of the raised funds and the safety of the raised funds are not affected; At the same time, appropriate cash management can improve the efficiency of capital use, obtain certain cash management income, and seek more return on investment for the company's shareholders. There is no conflict with the implementation plan of the project invested by the raised funds, and there is no change in the purpose of the raised funds in a disguised form.

5、 The company's use of idle raised funds for cash management within 12 months before the announcement date

Tecon Biology Co.Ltd(002100)

Order the client's counterparty's product name subscription amount expected annual value date maturity date whether the capital source is due (RMB 10000) return redemption yield (%)

1 Tecon Biology Co.Ltd(002100) China construction unit Association 43000.071 15% - temporarily idle from December 2021 to December 2022

Joint stock limited bank fixed deposit 1.65% whether the fund raised on December 6 has not reached the date of Urumqi

Railway Sub Branch

2 Tecon Biology Co.Ltd(002100) Industrial Bank enterprise gold 55569.261 15% - 2021 - December 2022: whether to temporarily idle or not, 1.90% of the financing customers of the company limited by shares have not reached the date of Urumqi general agreement of the company on December 6

Muqi branch fixed deposit

Note: as of the date of this announcement, the balance of the company's cash management with idle raised funds was 571371900 yuan (including the cash management products involved this time). The maximum amount of the company's cash management with idle raised funds in a single day was 985693300 yuan, which did not exceed the limit of cash management with idle raised funds authorized by the board of directors.

6、 Documents for future reference

1. Relevant bank agreement.

It is hereby announced.

Tecon Biology Co.Ltd(002100) board of directors

December 15, 2001

 

- Advertisment -